The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Adherence to COPD treatment in Turkey and Saudi Arabia: results of the ADCARE study
Open accessAbstract
Background: COPD affects millions of people worldwide. Poor treatment adherence contributes to increased symptom severity, morbidity and mortality. This study was designed to investigate adherence to COPD treatment in Turkey and Saudi Arabia. Methods: An observational, cross-sectional study in adult COPD patients in Turkey and Saudi Arabia. Through physician-led interviews, data were collected on sociodemographics and disease history, including the impact of COPD on health status using the COPD Assessment Test (CAT); quality of life, using the EuroQol Five-Dimension questionnaire (EQ-5D); and anxiety and depression using the Hospital Anxiety and Depression Scale (HADS). Treatment adherence was measured using the 8-item Morisky Medication Adherence Scale (MMAS-8). Multivariate logistic regression analysis examined the predictors of non-adherence and the impact of adherence on symptom severity. Results: Four hundred and five COPD patients participated: 199 in Turkey and 206 in Saudi Arabia. Overall, 49.2% reported low adherence (MMAS-8 <6). Of those, 74.7% reported high disease impact (CAT >15) compared to 58.4% reporting medium/high adherence ( p =0.0008). Patients with low adherence reported a lower mean 3-level EQ-5D utility value (0.54±0.35) compared to those with medium/high adherence (0.64±0.30; p <0.0001). Depression with HADS score 8–10 or >10 was associated with lower adherence (OR 2.50 [95% CI: 1.43–4.39] and 2.43 [95% CI: 1.39–4.25], respectively; p =0.0008). Being a high school/college graduate was associated with better adherence compared with no high school (OR 0.57 [95% CI: 0.33–0.98] and 0.38 [95% CI: 0.15–1.00], respectively; p =0.0310). After adjusting for age, gender, and country, a significant association between treatment adherence (MMAS-8 score ≥6) and lower disease impact (CAT ≤15) was observed (OR 0.56 [95% CI: 0.33–0.95]; p =0.0314). Conclusion: Adherence to COPD treatment is poor in Turkey and Saudi Arabia. Non-adherence to treatment is associated with higher disease impact and reduced quality of life. Depression, age, and level of education were independent determinants of adherence. Keywords: COPD, non-adherence, 8-item Morisky Medication Adherence Scale, MMAS-8, EuroQol Five-Dimension questionnaire, EQ-5D, COPD Assessment Test, CAT, Turkey, Saudi Arabia
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it was demonstrated that the prevalence of low medication adherence was 64.2% among COPD patients in Saudi Arabia and neighboring regions”
From Chronic Obstructive Pulmonary Disease in the Gulf Cooperation Council: Acute-Care Utilization and Medication Adherence: A PRISMA-ScR Scoping Review (2026) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“and a significant predictor of low adherence included living in Saudi Arabia rather than Turkey (OR = 3.20).”
From Chronic Obstructive Pulmonary Disease in the Gulf Cooperation Council: Acute-Care Utilization and Medication Adherence: A PRISMA-ScR Scoping Review (2026) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“Previous regional studies, including the ADCARE study, demonstrated suboptimal adherence to COPD treatments among patients in Saudi Arabia and neighboring countries and suggested associations between lower adherence and poorer clinical outcomes [9].”
From Chronic Obstructive Pulmonary Disease in the Gulf Cooperation Council: Acute-Care Utilization and Medication Adherence: A PRISMA-ScR Scoping Review (2026) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Retracted: Predictive Validity of a Medication Adherence Measure in an Outpatient Setting
Morisky, D. E., Ang, A., Krousel‐Wood, M., & Ward, H. J. (2008) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.07572.x · Cited by 2,877 · cited 1×
“0 were categorized as medium and high adherence, respectively.(17) Written permission was obtained from the copyright owners of the MMAS-8 questionnaire for any excerpts from copyrighted works that are included and the sources have been credited in the article.”
MethodRetractedThe Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Wang, H., Naghavi, M., Allen, C., Barber, R. M., Bhutta, Z. A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., Coates, M. M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31012-1 · Cited by 6,596
EuroQol: the current state of play
Brooks, R. (1996) · Health Policy · doi:10.1016/0168-8510(96)00822-6 · Cited by 5,815
DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2101 · Cited by 4,177 · cited 1×
“49 An association between depression and poor treatment adherence in chronic disease, 50 and specifically in respiratory diseases such as asthma 51 and COPD, 52 has been reported in the literature.”
Development and first validation of the COPD Assessment Test
Jones, P. W., Harding, G., Berry, P., Wiklund, I., Chen, W.-H., & Kline Leidy, N. (2009) · European Respiratory Journal · doi:10.1183/09031936.00102509 · Cited by 3,198 · cited 1×
“PrOs The impact of COPD on health status was assessed using the 8-item COPD Assessment Test (CAT).(11) In this study, a CAT score of ,10 equates to low impact, 10–15 signifies medium impact, and .”
Method
Research works printed but not linked: 1
- [26]National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health Reports of the Surgeon General The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General Atlanta, GA Centers for Disease Control and Prevention (US) 2014 24455788
Cited by
Volpato, E., Toniolo, S., Pagnini, F., & Banfi, P. I. (2021) · International Journal of COPD · doi:10.2147/copd.s313841 · Cited by 160
Psychological co-morbidities in COPD: Targeting systemic inflammation, a benefit for both?
Pelgrim, C. E., Peterson, J. D., Gosker, H. R., Schols, A. M. W. J., van Helvoort, A., Garssen, J., Folkerts, G., & Kraneveld, A. D. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.10.001 · Cited by 89
Bhattarai, B., Walpola, R. L., Mey, A., Anoopkumar‐Dukie, S., & Khan, S. A. (2020) · Respiratory Care · doi:10.4187/respcare.07355 · Cited by 96
“Eligible studies included participants of any age or sex with a diagnosis of COPD (regardless of other comorbid conditions) or health care professionals involved in the management of COPD.”
InfluentialXie, H., Jiang, Y., Liu, L., Peng, H., Li, J., & Chen, Z. (2023) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2023.111537 · Cited by 46
Adherence to Therapy in Chronic Obstructive Pulmonary Disease: A Systematic Review
Świątoniowska-Lonc, N., Chabowski, M., Polański, J., Mazur, G. J., & Jankowska‐Polańska, B. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2019_477 · Cited by 37
Metadata
- Authors
- Kokturk, N., Polatli, M., Oguzulgen, I. K., Saleemi, S., Al Ghobain, M., Khan, J., Doble, A., Tariq, L., Aziz, F., & El Hasnaoui, A.
- Affiliations
- King Faisal Specialist Hospital & Research Centre (SA)
- King Fahd Armed Forces Hospital (SA)
- Venue
- International Journal of Chronic Obstructive Pulmonary Disease
- Publisher
- Informa UK Limited
- Published
- 2018-04
- Volume
- Volume 13
- Pages
- 1377-1388
- ISSN
- 1176-9106 (ISSN-L)
- 1178-2005
- PMC
- PMC5927343
- OpenAlex
- W2802197918
- Semantic Scholar
- 8634df099c8011e09be4c843da62aec03b4e41f4
- Cited by
- 53
- References
- 63
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 11 · 2023: 12 · 2022: 3 · 2021: 9 · 2020: 7 · 2019: 4 · 2018: 1
- FWCI
- 5.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of COPD (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- EuroQol Research Foundation
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- chronic obstructive pulmonary disease, medication adherence, predictors of non-adherence, depression, anxiety, quality of life, disease impact, symptom severity, educational attainment, Turkey, Saudi Arabia, Morisky Medication Adherence Scale, COPD Assessment Test, EQ-5D, Hospital Anxiety and Depression Scale, cross-national comparison, patient-reported outcomes
- MeSH terms
- Adult, Age Factors, Cross-Sectional Studies, Depression, Educational Status, Health Status, Humans, Interviews as Topic, Health Knowledge, Attitudes, Practice, Mental Health, Middle Aged, Quality of Life, Surveys and Questionnaires, Risk Factors, Saudi Arabia, Severity of Illness Index, Turkey, Multivariate Analysis, Chi-Square Distribution, Logistic Models, Odds Ratio, Treatment Outcome, Pulmonary Disease, Chronic Obstructive, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.